Navigation Links
Natreon receives a US Patent on a plant-based Terminalia chebula extract
Date:1/22/2020

Natreon, a nutritional ingredient company, is proud to announce the grant of a U.S. Patent (US 10,500,240) on Terminalia chebula. This newly granted patent expands Natreon’s strong patent portfolio to a total of 24 active patents, as well as 40 published clinical trials.

The primary claim in this patent is, “a method of treating osteoarthritis in a mammal, comprising administering to a mammal in need thereof a therapeutically effective amount of a composition comprising a Terminalia chebula extract comprising a hydrolyzable tannoid blend, said blend comprising about 8-25% by weight chebulagic acid based on the total weight of the extract and about 15-30% by weight chebulinic acid based on the total weight of the extract.” The secondary claim is “a method of reducing pain and inflammation in an individual with osteoarthritis in need thereof, comprising orally administering to the individual in need thereof a therapeutically effective amount of a composition comprising a Terminalia chebula extract comprising a hydrolyzable tannoid blend, said blend comprising about 8-25% by weight chebulagic acid based on the total weight of the extract and about 15-30% by weight chebulinic acid based on the total weight of the extract.” The published randomized, double-blind, placebo-controlled clinical study tested 100 subjects with joint discomfort. Based on the information from which this patent has been issued, the results have shown a significant reduction in WOMAC, KSI, and VAS scores for pain and stiffness.

“Natreon is centered on the idea of ‘trusted science, naturally’ and our investment in clinical research demonstrates our commitment to this ideal. We are excited by the opportunities ahead as the market continues to seek botanical products backed by science”, says Bruce Brown, President of Natreon.

About Natreon:
Natreon is a leader in nutritional ingredient innovation, quality and research. Trusted by manufacturers for over 20 years, Natreon’s patented ingredients are derived from nature and founded on evidence-based Ayurveda. Committed to quality, its extracts are purified and standardized using proprietary process technology and controls that result in optimal levels of bioactive constituents. Natreon’s ingredients have been used in over 50 clinical trials that have supported 40 publications and 24 active patents. Natreon brings storied knowledge and expertise in botanical cultivation and extraction, and its ingredients are sustainably sourced through an integrated supply chain to ensure quality and potency. Natreon has its global headquarters in New Jersey and a state-of-the-art R&D facility in Kolkata, India. Natreon’s products include: Sensoril® ashwagandha, PrimaVie® shilajit, Capros® amla, Crominex®, AyuFlex®, Ayuric®, and introducing PhytoBGS®.For more information, visit: https://natreoninc.com/.

Contact:
Dr. Sanni Raju, CEO/Chairman or Bruce Brown, President
2-D Janine Place
New Brunswick, NJ 08901
732-296-1080

Read the full story at https://www.prweb.com/releases/natreon_receives_a_us_patent_on_a_plant_based_terminalia_chebula_extract/prweb16851908.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. New Clinical Trial - Natreon’s PrimaVie® Shilajit Ingredient Showed Results of Improved Skin Health in Adult Women
2. IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit
3. Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
6. BioElectronics Receives Working Capital Infusion
7. Inostics Blood-based Mutation Testing Receives CLIA Certification
8. Breathe Technologies Sleep System Receives FDA Clearance
9. Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants
10. Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com
11. Prime Therapeutics specialty pharmacy receives URAC accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2020)... PAUL, Minn. (PRWEB) , ... February 22, 2020 , ... ... to share ‘ Breaking Boundaries to Avoid a Food System Crisis ’ in ... Director Dr. Jennifer van de Ligt , delves deep into the boundaries that ...
(Date:2/23/2020)... ... February 23, 2020 , ... World-renowned actor ... The Scenes”. The show features a wide array of subjects impacting people all ... where medical experts will discuss the importance of preventative dentistry and proper oral ...
(Date:2/21/2020)... , ... February 21, 2020 , ... Special Learning, Inc. ... The company is passionate about changing the lives of people with autism and ... California focused on helping people find employment opportunities. Special Learning will be providing ...
Breaking Medicine Technology:
(Date:2/26/2020)... ... February 26, 2020 , ... Announcement Key Points: , ... Hera BioLabs company) which is best known for its commercialization of the piggyBac® ... as it is truly dimeric and demonstrates high fidelity with no detectable off-targets ...
(Date:2/23/2020)... ... February 22, 2020 , ... ... Investigation” Laurence Fishburne ( https://www.imdb.com/name/nm0000401/mediaindex ) is the host of the informational program ... variety of topics affecting people across the country. A soon to be aired ...
(Date:2/21/2020)... ... February 21, 2020 , ... Used for ... continues to garner traction as a viable replacement for invasive cosmetic surgery, such ... is predicted to remain the market leader for the expected robust growth of ...
(Date:2/20/2020)... VEGAS (PRWEB) , ... February 20, 2020 , ... R3 ... Heroes Program was able to complete 70 complimentary stem cell procedures on ... the regenerative therapies at no cost. , At the R3 Stem Cell Training Course ...
(Date:2/19/2020)... LOUIS (PRWEB) , ... February 19, 2020 , ... ... the availability of and application deadline for its new Lifestyle Medicine Residency Curriculum ... designed for integrated implementation into medical residency programs. Driven by resident involvement, ...
Breaking Medicine News(10 mins):